Ziagen's Heart Attack Link: How Long Has Glaxo Known?

[Guest guest]

Ziagen's Heart Attack Link: How Long Has Glaxo Known?We've known since February that Ziagen (abacavir) may increase an HIV-positive person's heart attack risk, especially for those who already have other risk factors for heart disease. But the company that makes the drug reportedly knew about Ziagen's possible heart risk two and a half years earlier. GlaxoKline was alerted about the possible heart risks associated with Ziagen back in May 2005, according to the British newspaper The Independent; however, the company publicly expressed surprise when the story broke early this year, and it has called into question the validity of the new study findings. (Article from The Independent)

Regards, VergelDirectorProgram for Wellness Restorationpowerusa dot orgWondering what's for Dinner Tonight? Get new twists on family favorites at AOL Food.